Cargando…

Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson’s disease

BACKGROUND: Resting-state functional magnetic resonance imaging (fMRI) studies have demonstrated that basal ganglia functional connectivity is altered in Parkinson’s disease (PD) as compared to healthy controls. However, such functional connectivity alterations have not been related to the dopaminer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Weihua, Lao-Kaim, Nick P., Roussakis, Andreas-Antonios, Martín-Bastida, Antonio, Valle-Guzman, Natalie, Paul, Gesine, Soreq, Eyal, Daws, Richard E., Foltynie, Tom, Barker, Roger A., Hampshire, Adam, Piccini, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490914/ https://www.ncbi.nlm.nih.gov/pubmed/32916466 http://dx.doi.org/10.1016/j.nicl.2020.102409

Ejemplares similares

Dissociable effects of age and Parkinson’s disease on instruction-based learning
por: Parkin, Beth L, et al.
Publicado: (2021)

Parkinson’s disease laterality: a (11)C-PE2I PET imaging study
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2020)

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
por: Roussakis, Andreas–Antonios, et al.
Publicado: (2019)

Dopamine Transporter Density in de novo Parkinson’s Disease Does Not Relate to the Development of Levodopa-Induced Dyskinesias
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2019)

Neuroimaging evidence for a network sampling theory of individual differences in human intelligence test performance
por: Soreq, Eyal, et al.
Publicado: (2021)

Astrogliosis in aging and Parkinson’s disease dementia: a new clinical study with (11)C-BU99008 PET
por: Mohamed, Mohamed A, et al.
Publicado: (2022)

Patterns of grey matter loss associated with motor subscores in early Parkinson's disease
por: Li, Xingfeng, et al.
Publicado: (2017)

Dopaminergic modulation of the praxis network in Parkinson's disease
por: Matt, Eva, et al.
Publicado: (2019)

Predicting clinical diagnosis in Huntington's disease: An imaging polymarker
por: Mason, Sarah L., et al.
Publicado: (2018)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
por: Cuevas, Elvis, et al.
Publicado: (2022)

Dopaminergic pathways and resting-state functional connectivity in Parkinson’s disease with freezing of gait
por: Steidel, Kenan, et al.
Publicado: (2021)

Normal aging and Parkinson's disease are associated with the functional decline of distinct frontal-striatal circuits
por: Gruszka, Aleksandra, et al.
Publicado: (2017)

Dynamic network coding of working-memory domains and working-memory processes
por: Soreq, Eyal, et al.
Publicado: (2019)

Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?
por: Macerollo, Antonella, et al.
Publicado: (2019)

Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
por: Winder-Rhodes, Sophie E., et al.
Publicado: (2015)

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
por: Concha‐Marambio, Luis, et al.
Publicado: (2021)

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease
por: Foo, Heidi, et al.
Publicado: (2016)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
por: Dadar, Mahsa, et al.
Publicado: (2018)

Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease
por: Wilson, Joanna, et al.
Publicado: (2020)

The Negative Relationship between Reasoning and Religiosity Is Underpinned by a Bias for Intuitive Responses Specifically When Intuition and Logic Are in Conflict
por: Daws, Richard E., et al.
Publicado: (2017)

Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson’s Disease
por: Redenšek, Sara, et al.
Publicado: (2020)

Restorative Strategies in Movement Disorders: the Contribution of Imaging
por: Lao-Kaim, Nicholas P., et al.
Publicado: (2017)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
por: Sossi, Vesna, et al.
Publicado: (2022)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

Functional connectivity between resting-state networks reflects decline in executive function in Parkinson’s disease: A longitudinal fMRI study
por: Boon, Lennard I., et al.
Publicado: (2020)

The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021)

Subtle changes in central dopaminergic tone underlie bradykinesia in essential tremor
por: Colella, Donato, et al.
Publicado: (2023)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis
por: Xing, Yue, et al.
Publicado: (2022)

Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition
por: Rowe, J. B., et al.
Publicado: (2008)

Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline
por: Morrison, Cassandra, et al.
Publicado: (2021)

Lower Circulating Lymphocyte Count Predicts ApoE ε4‐Related Cognitive Decline in Parkinson's Disease
por: Tsukita, Kazuto, et al.
Publicado: (2021)

Interactions between Kisspeptin Neurons and Hypothalamic Tuberoinfundibular Dopaminergic Neurons in Aged Female Rats
por: Iwata, Kinuyo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o3a2hiqnk7lmfu5f6b5n7miola